A Borri

503 total citations
10 papers, 304 citations indexed

About

A Borri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, A Borri has authored 10 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Immunology. Recurrent topics in A Borri's work include Renal cell carcinoma treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (2 papers). A Borri is often cited by papers focused on Renal cell carcinoma treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (2 papers). A Borri collaborates with scholars based in Italy and France. A Borri's co-authors include Aldo Alberto Beneduce, Valerio Di Carlo, Gianpaolo Balzano, Alessandro Zerbi, Giovanni Citterio, C Rugarli, Federico Caligaris‐Cappio, M. Franceschi, Anna Spreafico and Angelo Corti and has published in prestigious journals such as Clinical Cancer Research, International Journal of Cancer and European Journal of Cancer.

In The Last Decade

A Borri

10 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A Borri Italy	8	208	184	111	46	39	10	304
Martin Svatoň Czechia	10	220 1.1×	190 1.0×	112 1.0×	24 0.5×	28 0.7×	44	356
Diego Márquez-Medina Spain	10	308 1.5×	259 1.4×	102 0.9×	34 0.7×	35 0.9×	26	462
Ye-Young Rhee South Korea	11	217 1.0×	76 0.4×	111 1.0×	59 1.3×	22 0.6×	15	352
Koji Fukase Japan	10	150 0.7×	77 0.4×	102 0.9×	91 2.0×	43 1.1×	28	289
M Botturi Italy	8	102 0.5×	161 0.9×	85 0.8×	46 1.0×	24 0.6×	18	309
Akira Okimura Japan	8	141 0.7×	82 0.4×	112 1.0×	67 1.5×	27 0.7×	28	290
Sunao Ushijima Japan	9	171 0.8×	116 0.6×	156 1.4×	46 1.0×	51 1.3×	14	349
Kristen K. Ciombor United States	10	191 0.9×	78 0.4×	84 0.8×	66 1.4×	26 0.7×	26	315
Xiao Zhao China	9	202 1.0×	130 0.7×	84 0.8×	32 0.7×	29 0.7×	29	323
Qitao Yu China	12	284 1.4×	219 1.2×	188 1.7×	34 0.7×	26 0.7×	35	489

Countries citing papers authored by A Borri

Since Specialization

Citations

This map shows the geographic impact of A Borri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Borri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Borri more than expected).

Fields of papers citing papers by A Borri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Borri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Borri. The network helps show where A Borri may publish in the future.

Co-authorship network of co-authors of A Borri

This figure shows the co-authorship network connecting the top 25 collaborators of A Borri. A scholar is included among the top collaborators of A Borri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Borri. A Borri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Gregorc, Vanesa, Giovanni Citterio, Giordano Vitali, et al.. (2009). Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours. European Journal of Cancer. 46(1). 198–206. 47 indexed citations

Bandiera, Alessandro, Giulio Melloni, Massimo Freschi, et al.. (2009). Prognostic Factors and Analysis of S100a4 Protein in Resected Pulmonary Metastases from Renal Cell Carcinoma. World Journal of Surgery. 33(7). 1414–1420. 15 indexed citations

Zerbi, Alessandro, et al.. (2008). Pancreatic Metastasis From Renal Cell Carcinoma: Which Patients Benefit From Surgical Resection?. Annals of Surgical Oncology. 15(4). 1161–1168. 168 indexed citations

Tassi, Elena, Valeria Facchinetti, A Borri, et al.. (2006). Peptidome from Renal Cell Carcinoma Contains Antigens Recognized by CD4+ T Cells and Shared among Tumors of Different Histology. Clinical Cancer Research. 12(16). 4949–4957. 4 indexed citations

Kunz, Mathias, et al.. (2003). Management of true splenic artery aneurysms. Two case reports and review of the literature.. PubMed. 58(2). 247–56. 17 indexed citations

Bondanza, Attilio, Patrizia Rovere, A Borri, et al.. (2001). Cytokine secretion associated with the clearance of apoptotic bodies in renal cell carcinoma patients. International Journal of Cancer. 91(5). 713–717. 7 indexed citations

Anichini, Andrea, Annie Molla, Roberta Mortarini, A Borri, & Giorgio Parmiani. (1997). Frequency of CTL precursors and effectors directed to a single peptide of melan-A/Mart-1. Melanoma Research. 7(Supplement 1). S24–S24. 1 indexed citations

Besana, C, A Borri, Eugênio Bucci, et al.. (1994). Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous α-interferon. European Journal of Cancer. 30(9). 1292–1298. 16 indexed citations

Fortis, Claudio, Elisabetta Ferrero, C Besana, et al.. (1990). Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. phenotypic and functional analysis of the peripheral blood mononuclear cells. Cancer Immunology Immunotherapy. 32(3). 161–166. 16 indexed citations

10.

Franceschi, M., et al.. (1988). Fatal Aplastic Anemia in a Patient Treated with Carbamazepine. Epilepsia. 29(5). 582–583. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact